Analysts’ updated eps estimates for Thursday, September 7th:
Ashmore Group (OTCMKTS:AJMPF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Ashmore Group plc is an emerging market investment manager. It invests in the public equity and fixed income markets. Ashmore Group plc is based in London, United Kingdom. “
Grupo Aeroportuario del Sureste, S.A. de C.V. (NYSE:ASR) had its outperform rating reissued by analysts at Royal Bank Of Canada.
A V Homes (NASDAQ:AVHI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “AV Homes, Inc. is engaged in homebuilding, land development and other real estate operations in Florida and Arizona. The company also builds homes in central Florida and Phoenix under its Joseph Carl Homes brand. It owns and operates active adult communities, including Solivita near Orlando and CantaMia near Phoenix. AV Homes, Inc., formerly known as Avatar Holdings Inc., is based in Poinciana, Florida. “
Azure Power Global (NYSE:AZRE) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Azure Power Global Limited is a producer and developer of solar energy. The Company’s services include design, engineering and construction of grid integrated solar installations; off grid solar installations for villages, hamlets and remote areas; turnkey solar installations for commercial and residential complexes on roof tops, as back up and alternate source, and operation and maintenance of solar installations. Azure Power Global Limited is based in New Delhi, India. “
Bellerophon Therapeutics (NASDAQ:BLPH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $1.25 target price on the stock. According to Zacks, “Bellerophon Therapeutics LLC is a biotherapeutics company. It is focused on developing products for the treatment of cardiopulmonary and cardiac diseases. The company’s product pipeline consists of INOpulse and BCM which are in different clinical stage. Bellerophon Therapeutics LLC is based in Hampton, New Jersey. “
BioLineRx (NASDAQ:BLRX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company’s portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases. “
Popular (NASDAQ:BPOP) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $43.00 target price on the stock. According to Zacks, “Popular, Inc. is a diversified, publicly owned bank holding company. The corporation’s principal subsidiary, Banco Popular de Puerto Rico, has one of the largest retail franchise in Puerto Rico, operating numerous branches and automated teller machines. The Bank also operates branches in the U.S. Virgin Islands, the British Virgin Islands, and New York. “
Coeur Mining (NYSE:CDE) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada.
CSPC Pharmaceutical Group (NASDAQ:CHPTY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “CSPC Pharmaceutical Group Limited operates as a pharmaceutical group in China. Its bulk drug products include vitamin C, penicillin G and 7-ACA. The Company is also a major manufacturer of antibiotic finished drugs such as penicillin and cephalosporin products. CSPC Pharmaceutical Group Limited, formerly known as China Pharmaceutical Group Limited, is based in Wan Chai, Hong Kong. “
Farmers & Merchants Bancorp (NASDAQ:FMAO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $90.00 price target on the stock. According to Zacks, “Farmers & Merchants Bancorp, Inc. is the holding company for The Farmers & Merchants State Bank which operates as a locally owned and operated community bank serving Northwest Ohio and Northeast Indiana. The bank provides commercial banking, retail banking and other financial services through its 19 offices with locations in Fulton, Defiance, Henry, Williams, and Wood counties in Northwest Ohio. In Northeast Indiana they have offices located in DeKalb and Steuben counties. Farmers & Merchants Bancorp, Inc. is based in Archbold, Ohio. “
Franco Nevada Corp (NYSE:FNV) (TSE:FNV) had its outperform rating reissued by analysts at Royal Bank Of Canada.
Fox Factory Holding Corp. (NASDAQ:FOXF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $44.00 price target on the stock. According to Zacks, “Fox Factory Holding Corp. is a designer, manufacturer and marketer of suspension products used primarily on mountain bikes, side-by-side vehicles, on-road vehicles, off-road vehicles, all-terrain vehicles, snowmobiles, specialty vehicles and applications and motorcycles. Fox Factory Holding Corp. is headquartered in California. “
Forterra (NASDAQ:FRTA) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Forterra, Inc. is a manufacturer of concrete and clay building products. It operates primarily in the United States, Canada and the United Kingdom. Forterra, Inc. is headquartered in Irving, Texas. “
Netflix (NASDAQ:NFLX) had its buy rating reissued by analysts at Loop Capital. They currently have a $212.00 target price on the stock, up from their previous target price of $205.00.
Osisko Gold Royalties (NYSE:OR) had its outperform rating reissued by analysts at Royal Bank Of Canada.
Pan American Silver Corp. (NASDAQ:PAAS) (TSE:PAAS) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada.
Royal Gold (NASDAQ:RGLD) (TSE:RGL) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada.
Restoration Hardware Holdings (NYSE:RH) had its market perform rating reaffirmed by analysts at Cowen and Company. They currently have a $61.00 target price on the stock, up from their previous target price of $44.00.
Republic Services (NYSE:RSG) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada.
Saratoga Investment Corp (NYSE:SAR) had its outperform rating reiterated by analysts at Royal Bank Of Canada.
Sasol (NYSE:SSL) had its outperform rating reissued by analysts at Royal Bank Of Canada.
Silver Standard Resources (NASDAQ:SSRM) (TSE:SSO) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada.
